跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Deconsaph-Plus - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Deconsaph-Plus
Approved
STANDARD
Deconsaph-Plus
Enicar Pharmaceuticals Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6aefbed68645df59
Company
Enicar Pharmaceuticals Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
6aefbed68645df59
Drug Approval Philippines Name
Deconsaph-Plus
Product Name
Deconsaph-Plus
Registration Number
DRP-9434
Brand Name
Deconsaph-Plus
Generic Name
Guaifenesin + Phenylpropanolamine HCI + Chlorphenamine maleate
Dosage Form
Syrup
Dosage Strength
100 mg/6.5 mg/2 mg per 5 mL
Manufacturer
Enicar Pharmaceuticals Pvt. Ltd.
Trader
Sapphire Lifesciences Pvt. Ltd.
Importer
Nelpa Lifesciences, Inc.
Issuance Date
29 December 2020
Expiry Date
29 December 2025
Classification
Over-the-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6aefbed68645df59
Type
Standard
Back to Philippines FDA Approvals